ethyl pyruvate has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gribben, JG; Guan, XW; Jia, L; Liu, FT; Zhang, T | 1 |
1 other study(ies) available for ethyl pyruvate and Lymphoma, Large B-Cell, Diffuse
Article | Year |
---|---|
Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.
Topics: Animals; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Female; G1 Phase Cell Cycle Checkpoints; HMGB1 Protein; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins c-akt; Pyruvates; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor | 2019 |